Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Does natalizumab therapy worsen neuromyelitis optica?
Season of birth as a risk factor for multiple sclerosis in Brazil.
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
Therapeutic decision making in a new drug era in multiple sclerosis.
Imaging Phenotypes in Multiple Sclerosis.
Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
Anti-inflammatory genes associated with multiple sclerosis: A gene expression study.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Schwann cells in therapy of spinal cord injuries.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
Smoking and inflammation: evidence for a synergistic role in chronic disease.
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Cognitive rehabilitation in Multiple sclerosis.
MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
The trees and the forest: Characterization of complex brain networks with minimum spanning trees.
Co-Existence of Familial Mediterranean Fever and Multiple Sclerosis in Two Patients.
Design and analysis of three-arm trials with negative binomially distributed endpoints.
'Green Mice' display limitations in enhanced green fluorescent protein expression in retina and optic nerve cells.
Helicobacter pylori and neurological diseases: Married by the laws of inflammation.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
Magnetic Resonance Imaging Predictors of Executive Functioning in Patients with Pediatric-Onset Multiple Sclerosis.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Pages
« first
‹ previous
…
274
275
276
277
278
279
280
281
282
…
next ›
last »